We regularly have new studies that we are recruiting for. If you don’t see something that you qualify for right now, please call Caitlin at 952-993-9605 to be contacted about future studies.
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System (The 321 Study)
Principal Investigator: Anders Carlson, MD
Study sponsor: Medtronic
Locations: International Diabetes Center
Purpose of study: This study will test a new insulin pump system-the Medtronic Advanced Hybrid Closed Loop System (AHCL). This system consists of an insulin pump, a glucose sensor, and a transmitter. The system uses continuous glucose sensor information to tell the insulin pump how much insulin to infuse automatically to help control glucose levels in people who have type 1 diabetes. AHCL includes an updated version of the control mechanism in the currently available 670G insulin pump for the management of diabetes. The purpose of this study is to test how the AHCL system works for participants with type 1 diabetes.
The study is accepting males and females ages 7-75 years old who:
– Have type 1 diabetes and have used an insulin pump for at least 6 months
– Have a hemoglobin A1c less than 10%
– Are willing and able to upload glucose and pump data between visits
– Meet other study specific requirements